We shown that, in distinction to classical opioid receptors, ACKR3 won't result in classical G protein signaling and is not modulated via the classical prescription or analgesic opioids, such as morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists such as naloxone. Instead, we recognized that LIH383, an ACKR3-selective https://timi470cuj1.blog-ezine.com/profile